Published in Vaccine on June 02, 2008
Comparison of immunogenicity and persistence between inactivated hepatitis A vaccine Vealive® and Havrix® among children: A 5-year follow-up study. Hum Vaccin Immunother (2016) 0.76
Immune persistence after pertussis vaccination. Hum Vaccin Immunother (2017) 0.75
Assessment of antibody level and avidity against Bordetella pertussis in a cohort of Egyptian individuals aged 1-18 years. J Adv Res (2015) 0.75
Hepatitis C virus infection protein network. Mol Syst Biol (2008) 2.91
CD4+ T cell surface CCR5 density as a determining factor of virus load in persons infected with human immunodeficiency virus type 1. J Infect Dis (2000) 2.34
Quantitation of HCV RNA using real-time PCR and fluorimetry. J Virol Methods (2001) 1.62
[Maternofetal disseminated candidiasis and high-grade prematurity]. Arch Pediatr (1997) 1.42
The effect of metformin on the metabolic abnormalities associated with upper-body fat distribution. BIGPRO Study Group. Diabetes Care (1996) 1.41
CD4 T cell surface CCR5 density as a host factor in HIV-1 disease progression. AIDS (2001) 1.38
Serotyping and esterase typing for analysis of Listeria monocytogenes populations recovered from foodstuffs and from human patients with listeriosis in Belgium. J Clin Microbiol (1996) 1.38
ApoE deficiency compromises the blood brain barrier especially after injury. Mol Med (2001) 1.38
Localized reduction of atherosclerosis in von Willebrand factor-deficient mice. Blood (2001) 1.33
Molecular cloning of a lipolysis-stimulated remnant receptor expressed in the liver. J Biol Chem (1999) 1.26
Defect in regulated secretion of P-selectin affects leukocyte recruitment in von Willebrand factor-deficient mice. Proc Natl Acad Sci U S A (2001) 1.25
Inactivated poliovirus vaccine: past and present experience. Vaccine (1996) 1.22
Comparison of four methods for early detection of experimental Trichinella spiralis infections in pigs. Vet Parasitol (1981) 1.21
Oxidized low-density lipoprotein promotes mature dendritic cell transition from differentiating monocyte. J Immunol (2001) 1.17
Diphtheria and tetanus immunity among blood donors in Toronto. CMAJ (1997) 1.14
Association of signal-regulatory proteins beta with KARAP/DAP-12. Eur J Immunol (2000) 1.13
Safety and immunogenicity of two inactivated poliovirus vaccines in combination with an acellular pertussis vaccine and diphtheria and tetanus toxoids in seventeen- to nineteen-month-old infants. J Pediatr (1997) 1.10
Safety and immunogenicity of Haemophilus influenzae vaccine (tetanus toxoid conjugate) administered concurrently or combined with diphtheria and tetanus toxoids, pertussis vaccine and inactivated poliomyelitis vaccine to healthy infants at two, four and six months of age. Pediatr Infect Dis J (1994) 1.07
An adult formulation of a five-component acellular pertussis vaccine combined with diphtheria and tetanus toxoids is safe and immunogenic in adolescents and adults. Vaccine (2000) 1.05
Adverse reactions to the preschool (fifth) dose of adsorbed diphtheria-pertussis-tetanus vaccine in Canadian children. CMAJ (1991) 1.04
Prevention of human immunodeficiency virus-related opportunistic infections in France: a cost-effectiveness analysis. Clin Infect Dis (2002) 1.03
Modulation of HLA-G antigens expression by human cytomegalovirus: specific induction in activated macrophages harboring human cytomegalovirus infection. J Immunol (2000) 1.03
Mutational spectrometry without phenotypic selection: human mitochondrial DNA. Nucleic Acids Res (1997) 1.00
Listeria monocytogenes possesses adhesins for fibronectin. Infect Immun (1999) 1.00
[Environmental factors in the etiology of Parkinson's disease]. Can J Neurol Sci (1990) 1.00
Measles vaccination of infants in a well-vaccinated population. Pediatr Infect Dis J (1995) 0.97
In vivo regulation of von willebrand factor synthesis: von Willebrand factor production in endothelial cells after lung transplantation between normal pigs and von Willebrand factor-deficient pigs. Arterioscler Thromb Vasc Biol (1999) 0.96
Flow cytometric sorting and biochemical characterization of the late endosomal rab7-containing compartment. Electrophoresis (1997) 0.96
Platelet functions and haemostasis parameters in pigs: absence of side effects of a procedure of general anaesthesia. Thromb Res (1996) 0.95
Inhibitory effects of specific apolipoprotein C-III isoforms on the binding of triglyceride-rich lipoproteins to the lipolysis-stimulated receptor. J Biol Chem (1997) 0.95
New types of primers (stair primers) for PCR amplification of the variable V3 region of the human immunodeficiency virus. J Virol Methods (1996) 0.95
System-level comparison of protein-protein interactions between viruses and the human type I interferon system network. J Proteome Res (2010) 0.94
Clinical and epidemiological aspects of Listeriosis in Belgium, 1985-1990. Zentralbl Bakteriol (1991) 0.93
Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine. Vaccine (2012) 0.93
Effect of cyclosporin A and analogues on cytosolic calcium and vasoconstriction: possible lack of relationship to immunosuppressive activity. Br J Pharmacol (1996) 0.91
Accumulation of triglyceride-rich lipoprotein in subjects with abdominal obesity: the biguanides and the prevention of the risk of obesity (BIGPRO) 1 study. Arterioscler Thromb Vasc Biol (2001) 0.91
Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Biguanides and the Prevention of the Risk of Obesity. Diabetes Care (1998) 0.90
Mutational spectrometry: means and ends. Prog Nucleic Acid Res Mol Biol (1994) 0.90
Modulation of HLA-G antigens expression in myelomonocytic cells. Hum Immunol (2000) 0.90
Cyclin dependent kinase inhibitors prevent apoptosis of postmitotic mouse motoneurons. Life Sci (2006) 0.89
Interleukin 11 significantly increases plasma von Willebrand factor and factor VIII in wild type and von Willebrand disease mouse models. Blood (2001) 0.88
Sporadic case of listeriosis associated with the consumption of a Listeria monocytogenes-contaminated 'Camembert' cheese. J Infect (1997) 0.88
Treatment with metformin of non-diabetic men with hypertension, hypertriglyceridaemia and central fat distribution: the BIGPRO 1.2 trial. Diabetes Metab Res Rev (2000) 0.87
Sexually transmitted HCV infection and reinfection in HIV-infected homosexual men. Gastroenterol Clin Biol (2009) 0.86
Outcome of premature infants delivered after prolonged premature rupture of membranes before 25 weeks of gestation. Eur J Obstet Gynecol Reprod Biol (2000) 0.86
Structural compartmentalization of MHC class II signaling function. Immunol Today (1993) 0.85
Adult formulation of a five component acellular pertussis vaccine combined with diphtheria and tetanus toxoids and inactivated poliovirus vaccine is safe and immunogenic in adolescents and adults. Pediatr Infect Dis J (2000) 0.85
The PEN5 epitope identifies an oligodendrocyte precursor cell population and pilocytic astrocytomas. Am J Pathol (1999) 0.84
Can Haemophilus influenzae type b-tetanus toxoid conjugate vaccine be combined with diphtheria toxoid-pertussis vaccine-tetanus toxoid? CMAJ (1993) 0.83
Evaluation of booster doses of Haemophilus influenzae type b-tetanus toxoid conjugate vaccine in 18-month-old children. Vaccine (1995) 0.83
Recent evidence of underestimated circulation of hepatitis C virus intergenotypic recombinant strain RF2k/1b in the Rhône-Alpes region, France, January to August 2014: implications for antiviral treatment. Euro Surveill (2014) 0.83
Real-life evaluation of a human immunodeficiency virus screening algorithm using a single combined p24 antigen-antibody assay. Eur J Clin Microbiol Infect Dis (2012) 0.82
ANG II receptor expression and function during phenotypic modulation of rat aortic smooth muscle cells. Am J Physiol (1994) 0.82
[Post-cortisone lipo-atrophy treated by an autologous graft of adipose cell islets]. Ann Dermatol Venereol (1990) 0.81
Protection against experimental autoimmune encephalomyelitis by a proteasome modulator. J Neuroimmunol (2001) 0.81
Studies on the humoral immune response to a synthetic vaccine against Plasmodium falciparum malaria. Clin Exp Immunol (1991) 0.81
Modelling the long-term persistence of neutralizing antibody in adults after one dose of live attenuated Japanese encephalitis chimeric virus vaccine. Vaccine (2012) 0.81
[Medullary cancer of the thyroid]. Ann Otolaryngol Chir Cervicofac (1971) 0.81
Esculetin antagonizes iron-chelating agents and increases the virulence of Listeria monocytogenes. Res Microbiol (1997) 0.81
Cell-mediated and antibody immune responses to AIK-C and Connaught monovalent measles vaccine given to 6 month old infants. Vaccine (1999) 0.81
Invasive meningococcal disease epidemiology and control measures: a framework for evaluation. BMC Public Health (2007) 0.81
Sjögren's syndrome and cutaneous B cell lymphoma revealed by anetoderma. Arthritis Rheum (1993) 0.80
Percutaneous retrieval of a Strecker stent misplaced during TIPS. Cardiovasc Intervent Radiol (1996) 0.80
Effects of human recombinant, plasma-derived and porcine von Willebrand factor in pigs with severe von Willebrand disease. Blood Coagul Fibrinolysis (1998) 0.80
Post-marketing surveillance of adverse events following ProHIBit vaccine--British Columbia. Can Dis Wkly Rep (1989) 0.80
Comparison of a fifth dose of a five-component acellular or a whole cell pertussis vaccine in children four to six years of age. Pediatr Infect Dis J (1999) 0.80
A pilot study of iron depletion as adjuvant therapy in chronic hepatitis C patients not responding to interferon. Am J Gastroenterol (1999) 0.80
[Mycobacterium fortuitum skin infection occurring after a facelift]. Ann Dermatol Venereol (2004) 0.80
Pharmacokinetic drug interactions with macrolide antibiotics. J Antimicrob Chemother (1985) 0.80
Adverse reactions and antibody response to four doses of acellular or whole cell pertussis vaccine combined with diphtheria and tetanus toxoids in the first 19 months of life. Vaccine (1996) 0.79
Inhibitory effect on the lipolysis-stimulated receptor of the 39-kDa receptor-associated protein. J Biol Chem (1995) 0.79
Analysis of pentacyclic triterpenes by LC-MS. A comparative study between APCI and APPI. J Mass Spectrom (2009) 0.79
Advanced glycation end products (AGEs) activate mast cells. Br J Pharmacol (2010) 0.79
Differential effect of ritonavir and indinavir on immune response to hepatitis C virus in HIV-1 infected patients. AIDS (1999) 0.79
Mechanisms of leukocyte adhesion. Biorheology (1990) 0.79
[Deposits of immune complexes in rheumatoid nodule]. Ann Dermatol Venereol (1986) 0.79
[Epidemiology of hepatitis C virus infection in 1,304 HCV positive patients: variations according to the origin of transmission and year of diagnosis]. Gastroenterol Clin Biol (1998) 0.78
RAPD analysis, serotyping, and esterase typing indicate that the population of Listeria monocytogenes strains recovered from cheese and from patients with listeriosis in Belgium are different. Can J Microbiol (2001) 0.78
[Vertical partial surgery in cancers of the piriform sinus]. Ann Otolaryngol Chir Cervicofac (1965) 0.78
[Quality evaluation of primary health care in an urban area of southern Brazil]. Rev Saude Publica (1994) 0.78
Hepatitis E in liver transplant recipients in the Rhône-Alpes region in France. Eur J Clin Microbiol Infect Dis (2014) 0.78
Central sleep apnea in hypothyroidism. Am Rev Respir Dis (1983) 0.78
[Comparison of long-term carcinologic results between radical and conservative cervical surgery]. Ann Otolaryngol Chir Cervicofac (1975) 0.78
Measuring protection; a case study of pertussis vaccines--Swedish Trial II: secondary non-randomized comparisons between two schedules of infant vaccination. Dev Biol Stand (1998) 0.77
Polyunsaturated fatty acid enrichment increases ultraviolet A-induced lipid peroxidation in NCTC 2544 human keratinocytes. J Invest Dermatol (1995) 0.77
Immunogenicity of a five-component acellular pertussis vaccine in infants and young children. Arch Pediatr Adolesc Med (1994) 0.77
CD antigens 2001. J Leukoc Biol (2001) 0.77
Safety and immunogenicity of two acellular pertussis vaccines with different pertussis toxoid and filamentous hemagglutinin content in infants 2-6 months old. Scand J Infect Dis (1995) 0.77
Classification of natural resins by liquid chromatography-mass spectrometry and gas chromatography-mass spectrometry using chemometric analysis. J Chromatogr A (2012) 0.77
Role of magnetic resonance imaging in predicting late facial motor function after removal of vestibular schwannomas by the translabyrinthine approach. J Laryngol Otol (1995) 0.77
Centrifugal partition chromatography directly interfaced with mass spectrometry for the fast screening and fractionation of major xanthones in Garcina mangostana. J Chromatogr A (2008) 0.77
Clopidogrel-induced qualitative changes in thrombus formation correlate with stent patency in injured pig cervical arteries. Thromb Res (2002) 0.76
Controlled study of a new five-component acellular pertussis vaccine in adults and young children. J Infect Dis (1992) 0.76
Acellular pertussis vaccine as a booster dose for seventeen- to nineteen-month-old children immunized with either whole cell or acellular pertussis vaccine at two, four and six months of age. Pediatr Infect Dis J (1995) 0.76
Extended follow-up of antibody levels and antigen responsiveness after 2 Haemophilus influenzae type b conjugate vaccines. J Pediatr (1999) 0.76
Safety and immunogenicity of a five-component acellular pertussis vaccine with varying antigen quantities. Arch Pediatr Adolesc Med (1994) 0.76
Safety and immunogenicity of an acellular pertussis diphtheria tetanus vaccine given as a single injection with Haemophilus influenzae b conjugate vaccine. Vaccine (1997) 0.76